Keeping your nuclear medicine practices safe and compliant
The Australian Nuclear Medicine Traceability Program (ANMTP) assists practices administering nuclear medicine-based radionuclides to achieve regulatory compliance by providing measurement traceability to the Australian Standard. The program was developed in response to the need for radionuclide metrology within nuclear medicine practices, expressed by the Australian and New Zealand Society of Nuclear Medicine (ANZSNM).
Program outcomes:
- Improved patient outcomes through reliable dose administration for safe and effective diagnosis and treatment
- Increased accuracy and precision in the administration of radiopharmaceuticals
- Supports practices in meeting regulatory compliance obligations (e.g. ARPANSA Safety Guide to Radiation Protection in Nuclear Medicine)
Benefits
- Improved accuracy and precision in the administration of radiopharmaceuticals through direct comparison with the Australian standard for radioactivity
- Assistance to meet regulatory compliance obligations (e.g. ARPANSA Safety Guide to Radiation Protection in Nuclear Medicine)
- Improved patient outcomes through ongoing accurate and reliable administration of radiopharmaceuticals
Inclusions
- An onsite visit and dose calibrator measurement assessment by an ANSTO radionuclide metrologist
- Certified Reference Materials (calibration sources)
- A measurement report
- A certificate of traceability to the Australian Standard for the supplied Certified Reference Materials